Yu‐Ning Lin

1.0k total citations · 1 hit paper
32 papers, 750 citations indexed

About

Yu‐Ning Lin is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu‐Ning Lin has authored 32 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu‐Ning Lin's work include Bioactive Compounds and Antitumor Agents (4 papers), Pelvic floor disorders treatments (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Yu‐Ning Lin is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Pelvic floor disorders treatments (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Yu‐Ning Lin collaborates with scholars based in Taiwan, China and Malaysia. Yu‐Ning Lin's co-authors include Yanfei Wei, Wanjun Chen, Mei Jiang, Tiejian Zhao, Chao‐Jung Chen, T. M. Lin, Jiaxin Yu, Wen‐Chi Chen, Huey‐Yi Chen and Yung‐Hsiang Chen and has published in prestigious journals such as Frontiers in Immunology, Medicine and Ecotoxicology and Environmental Safety.

In The Last Decade

Yu‐Ning Lin

29 papers receiving 742 citations

Hit Papers

Cancer and ER stress: Mutual crosstalk between autophagy,... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ning Lin Taiwan 13 347 178 123 64 64 32 750
Hyonok Yoon South Korea 14 360 1.0× 128 0.7× 189 1.5× 52 0.8× 40 0.6× 28 889
Da Hyun Lee South Korea 17 361 1.0× 260 1.5× 102 0.8× 95 1.5× 35 0.5× 34 760
Bo Qian China 16 422 1.2× 114 0.6× 81 0.7× 93 1.5× 62 1.0× 45 794
Entaz Bahar South Korea 11 271 0.8× 107 0.6× 138 1.1× 49 0.8× 32 0.5× 18 687
Jie Hao China 22 544 1.6× 134 0.8× 68 0.6× 91 1.4× 79 1.2× 58 1.2k
Xiaolei Wang China 18 525 1.5× 234 1.3× 168 1.4× 54 0.8× 84 1.3× 44 1.2k
Weiwei Cai China 18 371 1.1× 109 0.6× 47 0.4× 110 1.7× 61 1.0× 47 896
Duan Wang China 19 411 1.2× 198 1.1× 65 0.5× 165 2.6× 48 0.8× 51 1.0k

Countries citing papers authored by Yu‐Ning Lin

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ning Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ning Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ning Lin more than expected).

Fields of papers citing papers by Yu‐Ning Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ning Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ning Lin. The network helps show where Yu‐Ning Lin may publish in the future.

Co-authorship network of co-authors of Yu‐Ning Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ning Lin. A scholar is included among the top collaborators of Yu‐Ning Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ning Lin. Yu‐Ning Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Huang‐Yu, Chung‐Ying Tsai, Hsiang‐Cheng Chi, et al.. (2025). Development of a compound herbal formulation (HBK) with antitumor and antioxidant functions for cancer adjuvant therapy. Phytomedicine. 147. 157212–157212. 2 indexed citations
2.
Wu, Yanmei, et al.. (2024). Metabolomics reveals the metabolic disturbance caused by arsenic in the mouse model of inflammatory bowel disease. Ecotoxicology and Environmental Safety. 287. 117305–117305. 1 indexed citations
3.
Zhang, Lili, et al.. (2024). Immune regulation and organ damage link adiponectin to sepsis. Frontiers in Immunology. 15. 1444884–1444884. 3 indexed citations
4.
Lin, Yu‐Ning, et al.. (2023). Identification of a potential prognostic plasma biomarker of acute ischemic stroke via untargeted LC‐MS metabolomics. PROTEOMICS - CLINICAL APPLICATIONS. 17(6). e2200081–e2200081. 7 indexed citations
5.
Gao, Xuejuan, et al.. (2023). HSP90-regulated CHIP/TRIM21/p21 Axis Involves in the Senescence ofOsteosarcoma Cells. Protein and Peptide Letters. 30(6). 513–519. 1 indexed citations
6.
Lin, Yu‐Ning, Mingyan Chen, Chun‐Yi Tsai, et al.. (2022). Prediction of Gastric Gastrointestinal Stromal Tumors before Operation: A Retrospective Analysis of Gastric Subepithelial Tumors. Journal of Personalized Medicine. 12(2). 297–297. 2 indexed citations
8.
Ho, Mao‐Wang, Te‐Mao Li, Ju‐Pi Li, et al.. (2021). Chinese Herbal Medicine Usage Reduces Overall Mortality in HIV-Infected Patients With Osteoporosis or Fractures. Frontiers in Pharmacology. 12. 593434–593434. 3 indexed citations
9.
Li, Yong, Maohua Huang, Songtao Li, et al.. (2021). 3′-Oxo-tabernaelegantine A (OTNA) selectively relaxes pulmonary arteries by inhibiting AhR. Phytomedicine. 92. 153751–153751. 7 indexed citations
10.
Wei, Yanfei, et al.. (2021). Computational and In Vitro Analysis of Plumbagin’s Molecular Mechanism for the Treatment of Hepatocellular Carcinoma. Frontiers in Pharmacology. 12. 594833–594833. 6 indexed citations
11.
Wu, Po‐Yuan, Te‐Mao Li, Chao‐Jung Chen, et al.. (2020). Complementary Chinese Herbal Medicine Therapy Improves Survival in Patients With Pemphigus: A Retrospective Study From a Taiwan-Based Registry. Frontiers in Pharmacology. 11. 594486–594486. 5 indexed citations
12.
Lin, Yu‐Ning, Chih‐Yuan Fu, Chien‐Hung Liao, et al.. (2020). Evaluating the advantages of treating acute cholecystitis by following the Tokyo Guidelines 2018 (TG18): a study emphasizing clinical outcomes and medical expenditures. Surgical Endoscopy. 35(12). 6623–6632. 15 indexed citations
13.
Lin, Yu‐Ning, Hsiu‐Hsin Tsai, Hsiu‐Li Huang, Yue‐Cune Chang, & Wann‐Yun Shieh. (2020). Rethinking potentially inappropriate medication use in nursing homes within the Chinese population. Geriatric Nursing. 41(6). 724–729.
14.
Chen, Yongxin, Chuan Zhao, Xuemei Liu, et al.. (2019). Plumbagin ameliorates liver fibrosis via a ROS-mediated NF-кB signaling pathway in vitro and in vivo. Biomedicine & Pharmacotherapy. 116. 108923–108923. 27 indexed citations
15.
Zhong, Jing, Junxuan Li, Lini Huo, et al.. (2019). Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Stromal Cell-Derived Factor (SDF-1)/CXCR4-CXCR7 Axis. Medical Science Monitor. 25. 6110–6119. 18 indexed citations
16.
Lv, Beibei, Jinling Xie, Yuan Zhang, et al.. (2019). <p>Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT</p>. Drug Design Development and Therapy. Volume 13. 2343–2355. 16 indexed citations
17.
Chen, Yung‐Hsiang, Chao‐Jung Chen, Yu‐Ning Lin, et al.. (2018). Downregulation of tight junction protein zonula occludens-2 and urothelium damage in a cyclophosphamide-induced mouse model of cystitis. Taiwanese Journal of Obstetrics and Gynecology. 57(3). 399–406. 7 indexed citations
18.
Lin, Yu‐Ning, Yongxin Chen, Jing Ma, et al.. (2018). Plumbagin induces autophagy and apoptosis of SMMC‐7721 cells in vitro and in vivo. Journal of Cellular Biochemistry. 120(6). 9820–9830. 27 indexed citations
19.
Gao, Liang, Ke Tao, Yu‐Ning Lin, et al.. (2017). Three-dimensional-printed upper limb prosthesis for a child with traumatic amputation of right wrist. Medicine. 96(52). e9426–e9426. 26 indexed citations
20.
Chen, Huey‐Yi, Chao‐Jung Chen, Yu‐Ning Lin, et al.. (2013). Proteomic analysis related to stress urinary incontinence following vaginal trauma in female mice. European Journal of Obstetrics & Gynecology and Reproductive Biology. 171(1). 171–179. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026